Increase in mucormycosis hospitalizations in southeastern Brazil during the COVID-19 pandemic: a 2010-2021 time series
Rev. Soc. Bras. Med. Trop
; Rev. Soc. Bras. Med. Trop;56: e0333, 2023. tab, graf
Article
en En
|
LILACS-Express
| LILACS
| ID: biblio-1422876
Biblioteca responsable:
BR1.1
ABSTRACT
ABSTRACT Background:
Mucormycosis is a severe invasive fungal disease. During the coronavirus disease 2019 (COVID-19) pandemic, outbreaks have been reported worldwide, but epidemiological studies are still scarce in Brazil.Methods:
We conducted a time-series cohort hospitalization study (2010-2021) in southeastern Brazil.Results:
There were 311 cases (85 during the pandemic), with significant (P < 0.05) involvement of patients older than 40 years (84%), white patients (78%), rhinocerebral site (63%), and São Paulo State residents (84%).Conclusions:
Mucormycosis hospitalizations were highly prevalent. Further studies are needed to assess the burden of COVID-19 on mucormycosis in Brazil.
Texto completo:
1
Índice:
LILACS
País/Región como asunto:
America do sul
/
Brasil
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
MEDICINA TROPICAL
Año:
2023
Tipo del documento:
Article